Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model

Yuko Iwata, Yoshimi Katayama, Yasushi Okuno, Shigeo Wakabayashi

Open source

DOI
10.18632/oncotarget.24449
Published
2018-02-08
Container
Oncotarget
Publisher
Impact Journals, LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.24449,
  title = {Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model},
  author = {Yuko Iwata and Yoshimi Katayama and Yasushi Okuno and Shigeo Wakabayashi},
  year = {2018},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.24449},
  url = {https://doi.org/10.18632/oncotarget.24449}
}

RIS

TY  - JOUR
TI  - Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model
AU  - Yuko Iwata
AU  - Yoshimi Katayama
AU  - Yasushi Okuno
AU  - Shigeo Wakabayashi
PY  - 2018
JO  - Oncotarget
DO  - 10.18632/oncotarget.24449
UR  - https://doi.org/10.18632/oncotarget.24449
ER  - 

APA

Iwata, Y., Katayama, Y., Okuno, Y., & Wakabayashi, S. (2018). Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model. Oncotarget. https://doi.org/10.18632/oncotarget.24449

Source records